Diamine Oxidase For Use In The Treatment Or Prevention Of Attention Deficit Hyperactivity Disorder (Adhd)

Patent No. EP2844277 (titled "Diamine Oxidase For Use In The Treatment Or Prevention Of Attention Deficit Hyperactivity Disorder (Adhd)") was filed by DR Healthcare Espaa on Apr 18, 2013. The application was issued on Mar 25, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KERNEBECK PATENTANWALTSOct 27, 2017KERNEBECK

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2844277

DR HEALTHCARE ESPAA
Application Number
EP13726296A
Filing Date
Apr 18, 2013
Status
Patent Maintained As Amended
Feb 21, 2020
Publication Date
Mar 25, 2020